Jolanda Howe
CIK: 0001974200
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Mirum Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (42 total)
- Oct 16, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct16.1K shares at avg. $19.24$310K - Sep 2, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct658 shares at avg. $100.00$66K - Aug 18, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct40K shares at avg. $100.00$4.0M - Aug 18, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct40K shares at avg. $6.27$251K - Aug 3, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct1.8K shares at avg. $105.29$194K - Jul 1, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct2.7K shares at avg. $120.00$327K - Jun 17, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct2.6K shares at avg. $101.95$264K - Mar 16, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct4.7K shares at avg. $91.98$435K - Mar 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct2.7K shares- - Mar 15, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct6K shares- - Feb 2, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct968 shares at avg. $103.30$100K - Jan 31, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct1.8K shares- - Jan 28, 2026MIRM
Mirum Pharmaceuticals, Inc.
Award(A)DirectRestricted Stock Units
5K shares- - Jan 28, 2026MIRM
Mirum Pharmaceuticals, Inc.
Award(A)DirectPerformance Restricted Stock Units
9K shares- - Jan 28, 2026MIRM
Mirum Pharmaceuticals, Inc.
Award(A)DirectStock Option (right to buy)
7.7K shares- - Jan 26, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct842 shares at avg. $96.19$81K - Jan 23, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct1.5K shares- - Jan 22, 2026MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct926 shares at avg. $93.33$86K - Jan 21, 2026MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct1.5K shares- - Aug 7, 2025MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct10K shares at avg. $58.00$580K - Aug 7, 2025MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct10K shares at avg. $6.27$63K - Jul 3, 2025MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct477 shares at avg. $49.08$23K - Jul 2, 2025MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct564 shares at avg. $48.25$27K - Jul 1, 2025MIRM
Mirum Pharmaceuticals, Inc.
Exercise(M)Direct1K shares- - Mar 18, 2025MIRM
Mirum Pharmaceuticals, Inc.
Sale(S)Direct2.4K shares at avg. $44.45$107K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 16, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 16,112 | $19.24 | $309,995 | Direct |
| Sep 2, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 658 | $100.00 | $65,800 | Direct |
| Aug 18, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 40,000 | $100.00 | $4,000,000 | Direct |
| Aug 18, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 40,000 | $6.27 | $250,800 | Direct |
| Aug 3, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 1,840 | $105.29 | $193,734 | Direct |
| Jul 1, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 2,721 | $120.00 | $326,520 | Direct |
| Jun 17, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 2,594 | $101.95 | $264,458 | Direct |
| Mar 16, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 4,732 | $91.98 | $435,239 | Direct |
| Mar 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 2,658 | - | $0 | Direct |
| Mar 15, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 6,000 | - | $0 | Direct |
| Feb 2, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 968 | $103.30 | $99,998 | Direct |
| Jan 31, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 1,771 | - | $0 | Direct |
| Jan 28, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award(A) Restricted Stock Units | 4,970 | - | - | Direct |
| Jan 28, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award(A) Performance Restricted Stock Units | 9,000 | - | - | Direct |
| Jan 28, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Award(A) Stock Option (right to buy) | 7,680 | - | - | Direct |
| Jan 26, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 842 | $96.19 | $80,994 | Direct |
| Jan 23, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 1,500 | - | $0 | Direct |
| Jan 22, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 926 | $93.33 | $86,419 | Direct |
| Jan 21, 2026 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 1,542 | - | $0 | Direct |
| Aug 7, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 10,000 | $58.00 | $580,000 | Direct |
| Aug 7, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 10,000 | $6.27 | $62,700 | Direct |
| Jul 3, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 477 | $49.08 | $23,411 | Direct |
| Jul 2, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 564 | $48.25 | $27,213 | Direct |
| Jul 1, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Exercise(M) | 1,041 | - | - | Direct |
| Mar 18, 2025 | MIRM Mirum Pharmaceuticals, Inc. | Sale(S) | 2,415 | $44.45 | $107,343 | Direct |
1-25 of 42 transactions
About Howe Jolanda
Howe Jolanda (SEC CIK 0001974200) files insider reports with the SEC as SVP, GLOBAL CONTROLLER of Mirum Pharmaceuticals, Inc. (MIRM).
Signal8 holds 20 ownership filings by Howe Jolanda, all Form 4s, filed between Nov 15, 2024 and Oct 19, 2026. Those filings report 42 transactions, from Nov 14, 2024 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Howe Jolanda's filings is in FOSTER CITY, CA.
Recent filings by Howe Jolanda
- Oct 16, 2026: Option exercise of MIRM shares (Form 4, code M).
- Sep 2, 2026: Open-market sale of MIRM shares (Form 4, code S).
- Aug 18, 2026: Open-market sale of MIRM shares (Form 4, code S).
- Aug 18, 2026: Option exercise of MIRM shares (Form 4, code M).
- Aug 3, 2026: Open-market sale of MIRM shares (Form 4, code S).
Other insiders filing for Mirum Pharmaceuticals, Inc. (MIRM)
- Myers Robert Paul, Chief Medical Officer
- Peetz Christopher, CHIEF EXECUTIVE OFFICER
- BJERKHOLT ERIC, CHIEF FINANCIAL OFFICER
- Walbert Timothy P, Director
- Cardon Lon, Director
- Ramasastry Saira, Director